NeoSculpt Plus

K252888 · S&M Medical Co., Ltd. · PBX · Mar 9, 2026 · General, Plastic Surgery

Device Facts

• Record ID: K252888
• Device Name: NeoSculpt Plus
• Applicant: S&M Medical Co., Ltd.
• Product Code: PBX · General, Plastic Surgery
• Decision Date: Mar 9, 2026
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4400
• Device Class: Class 2
• Attributes: Therapeutic, Pediatric

Intended Use

The NeoSculpt Plus is intended to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation.

Device Story

NeoSculpt Plus is a monopolar radiofrequency (RF) therapeutic device for hospital use by medical professionals. System includes main console, RF handpieces, and neutral electrodes. Device delivers high-frequency current (1 MHz or 2 MHz) through patient tissue; patient body acts as resistance to generate heat. Output produces moderate subcutaneous temperature rise (40°C–45°C). Clinician operates device via LCD capacitive touch screen to select parameters. Real-time monitoring of temperature, impedance, and electrode contact ensures safety. Output affects clinical decision-making by providing non-invasive thermal therapy for pain relief, muscle spasms, and circulation improvement. Benefits include controlled, localized tissue heating.

Clinical Evidence

Bench testing only. Testing verified technical parameters (frequency, power, timing) and validated the ability to maintain target skin temperatures (40.0°C to 45.0°C). Safety monitoring and alarm systems were verified. Software validation confirmed adherence to requirements and risk mitigation.

Technological Characteristics

Monopolar RF generator; 1 MHz and 2 MHz output frequencies; square/rectangle waveforms. Max power 260W; max voltage 200Vrms. Includes temperature sensors, impedance monitoring, and contact quality monitoring. Neutral electrodes consist of aluminum foil and conductive gel. User interface: LCD capacitive touch screen. Sterilization: non-sterile, multiple-use handpieces. Standards: AAMI ANSI ES60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2-2.

Indications for Use

Indicated for patients of all ages requiring topical heating for relief of pain, muscle spasms, and increased local circulation.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

• truSculpt iD (K223110)

Reference Devices

• Neutral electrodes (K092761)

Submission Summary (Full Text)

{0}

FDA U.S. FOOD & DRUG ADMINISTRATION

March 9, 2026

S&M Medical Co., Ltd.
% Edward Park
RA Consultant
Lighten Bridge LLC
4408 Tortuga Ln
McKinney, Texas 75070

Re: K252888
Trade/Device Name: NeoSculpt Plus
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical Cutting And Coagulation Device And Accessories
Regulatory Class: Class II
Product Code: PBX
Dated: February 3, 2026
Received: February 3, 2026

Dear Edward Park:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

{1}

K252888 - Edward Park
Page 2

(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13484 clause 8.3 (Nonconforming product), and ISO 13485 clause 8.5 (Corrective and preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and 21 CFR 820.70) and document changes and approvals in the Medical Device File (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

{2}

K252888 - Edward Park
Page 3

Sincerely,

Colin K. Chen -S
Digitally signed by
Colin K. Chen -S
Date: 2026.03.09
10:08:18 -04'00'

Colin Kejing Chen, Ph.D.
Acting Assistant Director
DHT4A: Division of General Surgery Devices
OHT4: Office of Surgical and
Infection Control Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

{3}

FORM FDA 3881 (8/23)
Page 1 of 1
PSC Publishing Services [phone]
EF

| DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use | Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below. |
| --- | --- |
| 510(k) Number (if known) K252888 | |
| Device Name NeoSculpt Plus | |
| Indications for Use (Describe) The NeoSculpt Plus is intended to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation. | |
| Type of Use (Select one or both, as applicable) ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | |
| CONTINUE ON A SEPARATE PAGE IF NEEDED. | |
| This section applies only to requirements of the Paperwork Reduction Act of 1995. *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* | |
| The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail] | |
| "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | |

{4}

K252888
S&M Medical Co., Ltd.
810~817 and WB, B1, 11,
Suite 212, 249 Chuam-ro, Buk-gu
Gwangju 61003 Republic of Korea
Tel. [phone]

# 510(k) Summary – Traditional 510(k)

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR §807.92.

## Submitter Information

Submitter Name: S&M Medical Co., Ltd.
Address: Suite 212, 249 Chuam-ro, Buk-gu, Gwangju 61003 Republic of Korea
Phone: [phone]
Contact Person: Edward Park, official correspondent of Biounit CO., LTD.
Preparation Date: September 10, 2025

## Device Information

Proprietary Name(s): NeoSculpt Plus
Common Name: General Purpose RF Therapeutic Device
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Product Code: PBX
Regulation Number: 21 CFR 878.4400
Classification Panel: General & Plastic Surgery
Device Class: II

## Device Description

The NeoSculpt Plus is a medical device designed for use by medical professionals in hospital settings. It delivers Radiofrequency (RF) energy to a patient for therapeutic treatment. The system is composed of a main console, one or more RF handpieces that connect to the console via umbilical cables, and neutral electrodes that attach to the patient's skin.

The NeoSculpt Plus provides topical heating to elevate tissue temperature, which can be used to treat various medical conditions, including the relief of pain and muscle spasms and to increase local circulation. The system operates by generating a high-frequency current that flows from the handpiece, through the patient's body (which acts as a resistance), and back to the console via the neutral electrode. This intensive current flow generates a heating profile that produces a moderate temperature rise in the subcutaneous tissue.

{5}

S&M MEDICAL

K252888

S&M Medical Co., Ltd.

810~817 and WB, B1, 11,

Suite 212, 249 Chuam-ro, Buk-gu

Gwangju 61003 Republic of Korea

Tel. [phone]

## Predicate Device

truSculpt iD (Cutera, Inc., K223110)

- Regulation Name: Electrosurgical cutting and coagulation device and accessories
- Device Class: II
- Product Code: GEI
- Regulation Number: 21 CFR 878.4400
- Classification Panel: General & Plastic Surgery

## Indications for Use

The NeoSculpt Plus is intended to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation.

## Technological Characteristics

The NeoSculpt Plus retains the same basic design components and operating features as the predicate device, truSculpt iD. The functionality of the user interface is also the same as the predicate device. The design of the subject device’s main console is also similar to that of the predicate device.

{6}

K252888

S&M Medical Co., Ltd.

810~817 and WB, B1, 11,

Suite 212, 249 Chuam-ro, Buk-gu

Gwangju 61003 Republic of Korea

Tel. [phone]

# S&M MEDICAL

# Substantial Equivalence Discussion

NeoSculpt Plus has been compared to the following predicate device.

| Device Name | Proposed Device | Predicate Device | Remark |
| --- | --- | --- | --- |
| | NeoSculpt Plus | truSculpt iD | |
| 510k number | | K223110 | |
| Manufacturer | S&M Medical Co., Ltd. | Cutera Inc. | |
| Product Code | PBX | GEI, PBX | Identical |
| Regulation Number | 878.4400 | 878.4400 | Identical |
| Indications for Use | The NeoSculpt Plus is intended to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation. | The truSculpt RF energy is intended to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation.
Additionally, the 2 MHz setting for the 40 cm² handpiece is indicated for reduction in circumference of the abdomen and non-invasive lipolysis (breakdown of fat) of the abdomen.
The truSculpt massage device is intended to provide a temporary reduction in the appearance of cellulite. | Substantially Equivalent
The differences in the indications for use do not constitute a new intended use. |
| Prescription or OTC | Prescription Use Only | Prescription Use Only | Identical |
| Intended Patient Population | All ages | All ages | Identical |

{7}

K252888

SSM MEDICAL

S&M Medical Co., Ltd.

810~817 and WB, B1, 11,

Suite 212, 249 Chuam-ro, Buk-gu

Gwangju 61003 Republic of Korea

Tel. [phone]

| Device Name | Proposed Device | Predicate Device | Remark |
| --- | --- | --- | --- |
| | NeoSculpt Plus | truSculpt iD | |
| 510k number | | K223110 | |
| Manufacturer | S&M Medical Co., Ltd. | Cutera Inc. | |
| Operational Principle | The electrosurgical generator is the source of the electron flow and voltage. The circuit is composed of the generator, active electrode, patient and patient return electrode. The patient's tissue provides the impedance, producing heat as the electrons overcome the impedance. This heat elevates soft tissues' temperature and causes treatment of selected medical conditions, such as the relief of minor aches, pain, and muscle spasms; an increase in local circulation; a reduction in circumference of the abdomen; and noninvasive lipolysis (breakdown of fat) of the abdomen. | The electrosurgical generator is the source of the electron flow and voltage. The circuit is composed of the generator, active electrode, patient and patient return electrode. The patient's tissue provides the impedance, producing heat as the electrons overcome the impedance. This heat elevates soft tissues' temperature and causes treatment of selected medical conditions, such as the relief of minor aches, pain, and muscle spasms; an increase in local circulation; a reduction in circumference of the abdomen; and noninvasive lipolysis (breakdown of fat) of the abdomen. | Identical |
| ESU | | | |
| RF type | Monopolar | Monopolar | Identical |
| Temperature sensors | Yes | Yes | Identical |
| Impedance monitor | Yes | Yes | Identical |

{8}

K252888

S&M Medical Co., Ltd.
810~817 and WB, B1, 11,
Suite 212, 249 Chuam-ro, Buk-gu
Gwangju 61003 Republic of Korea
Tel. [phone]

| Device Name | Proposed Device | Predicate Device | Remark |
| --- | --- | --- | --- |
| | NeoSculpt Plus | truSculpt iD | |
| 510k number | | K223110 | |
| Manufacturer | S&M Medical Co., Ltd. | Cutera Inc. | |
| Continuity monitor | Yes | Yes | Identical |
| Performance specifications | Output frequency: 1 MHz and 2 MHz
Waveform: Square or Rectangle
Power output: 260 W max.
Voltage output: 200V_{rms} | Output frequency: 1 MHz and 2 MHz
Waveform: Square or Rectangle
Power output: 300 W max.
Voltage output: 250 V_{rms} | Substantially Equivalent |
| Physical specifications | **Dimension**
410mm (W) × 410mm (D) × 1130mm (H)
**Weight:** 43.5 kg | **Dimension**
355mm (W) × 444.5mm (D) × 1054.1mm (H)
**Weight:** 22.7 kg | Substantially Equivalent |
| Software User Interface | Display panel | Display panel | Identical |
| Display type | LCD with Capacitive Touch Screen | LCD with Capacitive Touch Screen | Identical |
| Target Temperature Range & Accuracy | 40°C ~ 45°C (0.5°C increment) | 38°C ~ 45°C (0.5°C increment) | Substantially Equivalent |
| Treatment Duration | Handsfree (40cm² handpiece): 15min.
Handheld (40cm² handpiece): 3min.
Handheld (16cm² handpiece): 3min. | Handsfree (40cm² handpiece): 15min.
Handheld (40cm² handpiece): 15min.
Handheld (16cm² handpiece): 5min. | Proposed Device ≤ Predicate |

{9}

K252888

S&M Medical Co., Ltd.
810~817 and WB, B1, 11,
Suite 212, 249 Chuam-ro, Buk-gu
Gwangju 61003 Republic of Korea
Tel. [phone]

| Device Name | Proposed Device | Predicate Device | Remark |
| --- | --- | --- | --- |
| | NeoSculpt Plus | truSculpt iD | |
| 510k number | | K223110 | |
| Manufacturer | S&M Medical Co., Ltd. | Cutera Inc. | |
| Active accessory - Handpiece | | | |
| Electrode type | Monopolar | Monopolar | Identical |
| Area treated | 16cm², 40cm² handpiece | 16cm² ~ 40cm² handpiece | Substantially Equivalent |
| Rated voltage | 200V_{rms} | 250 Vrms | Substantially Equivalent |
| Frequency | 1 MHz and 2 MHz | 1 MHz and 2 MHz | Identical |
| Impedance Matching | 100 - 200 Ω range | 100 - 200 Ω range | Identical |
| Maximum Power | 130 Watts × 2 ea | 150 Watts × 2 ea | The Subject device has lower max.power and lower max.power density than the predicate. |
| Temperature Monitoring | Yes | Yes | Identical |
| Neutral electrodes (K092761) | | | |
| Conductive or capacitive | Conductive | Conductive | Identical |

{10}

K252888

SSM MEDICAL

S&M Medical Co., Ltd.

810~817 and WB, B1, 11,

Suite 212, 249 Chuam-ro, Buk-gu

Gwangju 61003 Republic of Korea

Tel. [phone]

| Device Name | Proposed Device | Predicate Device | Remark |
| --- | --- | --- | --- |
| | NeoSculpt Plus | truSculpt iD | |
| 510k number | | K223110 | |
| Manufacturer | S&M Medical Co., Ltd. | Cutera Inc. | |
| Physical Type | Split Plate | Split Plate | Identical |
| Physical Dimension | 136cm² | 136cm² | Identical |
| Material | Aluminum foil + conductive gel | Aluminum foil + conductive gel | Identical |
| Contact Quality Monitoring | Yes | Yes | Identical |

{11}

S&M MEDICAL

K252888

S&M Medical Co., Ltd.

810~817 and WB, B1, 11,

Suite 212, 249 Chuam-ro, Buk-gu

Gwangju 61003 Republic of Korea

Tel. [phone]

# Discussion

The subject and predicate devices are based on the following same technological elements:

- All devices use electrical energy to generate high-frequency (RF) energy as a means to elevate the temperature of target soft tissues.
- All instrument sets are comprised of ergonomic user interface (e.g. handpiece, neutral electrode, user stop switch, etc.) and connectors (e.g. cable) to the ESU.
- The handpieces of the subject device come in two configurations, namely handheld mode and a handsfree mode. These modes are consistent with those of the predicate device which also comes in the two configurations.
- The handpieces are for multiple use and provided non-sterile.

Some differences in their technological characteristics, including power output, voltage output, and physical specifications do not raise different questions of safety and effectiveness, as demonstrated by the following data:

- Performance Specifications

The NeoSculpt Plus has a lower maximum power output (260 W) and a lower voltage output (200 V_rms) compared to the truSculpt iD (300 W and 250 V_rms). These differences in performance are addressed and justified by the accompanying bench test report and electrical safety test report. These reports confirm that despite the lower power and voltage, the NeoSculpt Plus still achieves the same therapeutic effects as the predicate device without compromising safety.

- Physical Specifications

The overall dimensions and weight of the console units are different. The NeoSculpt Plus is larger and heavier than the truSculpt iD, and the physical design and dimensions of the handpieces also differ. The usability report demonstrated that the physical specifications of the subject device do not impact the device's fundamental function or raise new safety or effectiveness concerns.

Non-clinical test was performed in accordance with the following international standards,

# A. Electromagnetic Compatibility and Electrical Safety Test

- AAMI ANSI ES60601-1:2005+AMD1:2012, Medical Electrical Equipment – Part 1; General Requirements for Basic Safety and Essential Performance (IEC 60601-1:2005, MOD)
- IEC 60601-1-2:2014, Medical Electrical Equipment – Part 1-2: General Requirements for Basic Safety and Essential Performance – Collateral Standard: Electromagnetic Disturbances – Requirements and Tests
- IEC 60601-1-6:2010+AMD1:2013, Medical Electrical Equipment – Part 1-6: General Requirements for Basic Safety and Essential Performance – Collateral Standard: Usability

{12}

K252888
S&M Medical Co., Ltd.
810~817 and WB, B1, 11,
Suite 212, 249 Chuam-ro, Buk-gu
Gwangju 61003 Republic of Korea
Tel. [phone]

# S&M MEDICAL

- IEC 60601-2-2:2017, Medical Electrical Equipment – Part 2 Particular Requirements for Basic Safety and Essential Performance of high frequency surgical equipment and high frequency surgical accessories

## B. Bench Test

The NeoSculpt Plus demonstrated substantial equivalence to the predicate TruSculpt iD through comprehensive bench testing. Testing confirmed the accuracy of technical parameters (frequency, power, and timing) and validated the device’s ability to maintain target skin temperatures (40.0 °C to 45.0 °C) on human subjects. Verification of safety monitoring and alarm systems further supports the conclusion that the device is as safe and effective as the predicate.

## C. Software Verification and Validation

- ANSI AAMI IEC 62304:2006, Medical Device Software – Software Life Cycle Processes
- ANSI AAMI IEC 62366, Medical devices Part 1: Application of usability engineering to medical devices
- EN ISO 14971:2007 Medical devices - Applications of risk management to medical devices
- FDA Guidance for Content of Premarket Submissions for Device Software Functions

System validation testing presented in this 510(k) demonstrated that all software requirement specifications are met, and all software hazards have been mitigated to acceptable risk levels.

## Conclusion

The subject device is substantially equivalent in the areas of indications for use, general functions & features, principle of operation, technological characteristics, and applicable safety standards. The new device does not introduce fundamentally new scientific technology, and the successful results of bench testing and clinical accuracy validation should be sufficient evidence of substantial equivalence. Therefore, we conclude that the subject device described in this submission is substantially equivalent to the predicate device.